Facial basal cell carcinomas recurring after photodynamic therapy: A retrospective analysis of histological subtypes

Dermatology

Volumn 224, Issue 4, 2012, Pages 346-351

  Fiechter, Sabine ^a   Skaria, André ^a,b   Nievergelt, Helga ^a   Anex, Romain ^a   Borradori, Luca ^a   Parmentier, Laurent ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Centre de Dermatochirurgie   (Switzerland)

Author keywords

Facial basal cell carcinoma; Histological subtypes; Photodynamic therapy; Recurrence; Retrospective analysis

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER GROWTH; CANCER THERAPY; CLINICAL ARTICLE; FACE CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; TUMOR LOCALIZATION;

AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; FACE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864874730     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000339335     Document Type: Article

References (32)

1. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM: Incidence estimate of nonmel-anoma skin cancer in the United States, 2006. Arch Dermatol 2010; 146:283-287.
2. Mosterd K, Krekels GA, Nieman FH, Oster-tag JU, Essers BA, Dirksen CD, Steijlen PM, Vermeulen A, Neumann H, Kelleners-Smeets NW: Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 2008; 9: 1149-1156.
3. Kiiski V, de Vries E, Flohil SC, Bijl MJ, Hof-man A, Stricker BH, Nijsten T: Risk factors for single and multiple basal cell carcinomas. Arch Dermatol 2010; 146:848-855.
4. Skaria AM: Recurrence of basosquamous carcinoma after Mohs micrographic surgery. Dermatology 2010; 221:352-355.
5. Fritsch C, Goerz G, Ruzicka T: Photodynam-ic therapy in dermatology. Arch Dermatol 1998; 134: 207-214.
6. Rhodes LE, de Rie M, Enstrom Y, Groves R, Morken T, Goulden V, Wong GA, Grob JJ, Varma S, Wolf P: Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of Amulticenter randomized prospective trial. Arch Dermatol 2004; 140:17-23.
7. Rhodes LE, de Rie MA, Leifsdottir R, Yu RC, Bachmann I, Goulden V, Wong GA, Richard MA, Anstey A, Wolf P: Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol 2007; 143: 1131-1136.
8. Lehmann P: Methyl aminolaevulinate-pho-todynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol 2007; 156: 793-801.
9. Horn M, Wolf P, Wulf HC, Warloe T, Fritsch C, Rhodes L E, Kaufmann R, DeRie M, Legat FJ, Stender IM, Soler AM, Wennberg AM, Wong GA, Larko O: Topical methyl amino-laevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003; 149:1242-1249.
10. Vinciullo C, Elliott T, Francis D, Gebauer K, Spelman L, Nguyen R, Weightman W, Sheridan A, Reid C, Czarnecki D, Murrell D: Pho-todynamic therapy with topical methyl ami-nolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol 2005; 152:765-772.
11. Sexton M, Jones DB, Maloney ME: Histolog-ic pattern analysis of basal cell carcinoma. Study of a series of 1,039 consecutive neoplasms. J Am Acad Dermatol 1990; 23: 1118-1126.
12. Kuijpers DI, Smeets NW, Krekels GA, This-sen MR: Photodynamic therapy as adjuvant treatment of extensive basal cell carcinoma treated with Mohs micrographic surgery. Dermatol Surg 2004; 30: 794-798.
13. Menn H, Robins P, Kopf AW, Bart RS: The recurrent basal cell epithelioma. A study of 100 cases of recurrent, re-treated basal cell epithe-liomas. Arch Dermatol 1971; 103:628-631.
14. Boulinguez S, Grison-Tabone C, Lamant L, Valmary S, Viraben R, Bonnetblanc JM, Be-dane C: Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions. Br J Dermatol 2004; 151: 623-626.
15. Lang PG Jr, Maize JC: Histologic evolution of recurrent basal cell carcinoma and treatment implications. J Am Acad Dermatol 1986; 14: 186-196.
16. Scrivener Y, Grosshans E, Cribier B: Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 2002; 147:41-47.
17. Izikson L, Seyler M, Zeitouni NC: Prevalence of underdiagnosed aggressive non-melanoma skin cancers treated with Mohs micro-graphic surgery: analysis of 513 cases. Dermatol Surg 2010; 36:1769-1772.
18. Haws AL, Rojano R, Tahan SR, Phung TL: Accuracy of biopsy sampling for subtyping basal cell carcinoma. J Am Acad Dermatol 2012; 66:106-111.
19. Cohen PR, Schulze KE, Nelson BR: Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer. Dermatol Surg 2006; 32:542-551.
20. Fink-Puches R, Soyer HP, Hofer A, Kerl H, Wolf P: Long-term follow-up and histologi-cal changes of superficial nonmelanoma skin cancers treated with topical delta-ami-nolevulinic acid photodynamic therapy. Arch Dermatol 1998; 134: 821-826.
21. Wagner RF Jr, Cottel WI: Multifocal recurrent basal cell carcinoma following primary tumor treatment by electrodesiccation and curettage. J Am Acad Dermatol 1987; 17: 1047-1049.
22. Wetzig T, Woitek M, Eichhorn K, Simon JC, Paasch U: Surgical excision of basal cell carcinoma with complete margin control: out-come at 5-year followup. Dermatology 2010; 220:363-369.
23. Mogensen M, Jemec GB: Diagnosis of non-melanoma skin cancer/keratinocyte carcinoma: a review of diagnostic accuracy of nonmelanoma skin cancer diagnostic tests and technologies. Dermatol Surg 2007; 33: 1158-1174.
24. Wolf P, Fink-Puches R, Reimann-Weber A, Kerl H: Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site. Dermatology 1997; 194: 53-54.
25. Maydan E, Nootheti PK, Goldman MP: Development of a keratoacanthoma after topical photodynamic therapy with 5-aminolev-ulinic acid. J Drugs Dermatol 2006; 5:804-806.
26. Sharfaei S, Viau G, Lui H, Bouffard D, Bis-sonnette R: Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice. Br J Dermatol 2001; 144:1207-1214.
27. Stender IM, Bech-Thomsen N, Poulsen T, Wulf HC: Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photo-chem Photobiol 1997; 66: 493-496.
28. Sharfaei S, Juzenas P, Moan J, Bissonnette R: Weekly topical application of methyl ami-nolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice. Arch Dermatol Res 2002; 294: 237-242.
29. Finlan LE, Kernohan NM, Thomson G, Beattie PE, Hupp TR, Ibbotson SH: Differential effects of 5-aminolaevulinic acid photo-dynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo. Br J Dermatol 2005; 153: 1001-1010.
30. Nishigori C, Hattori Y, Toyokuni S: Role of reactive oxygen species in skin carcinogen-esis. Antioxid Redox Signal 2004; 6:561-570.
31. Fantini F, Greco A, Cesinaro AM, Surrenti T, Peris K, Vaschieri C, Marconi A, Giannetti A, Pincelli C: Pathologic changes after pho-todynamic therapy for basal cell carcinoma and Bowen disease: a histologic and immu-nohistochemical investigation. Arch Dermatol 2008; 144: 186-194.
32. Espada J, Galaz S, Sanz-Rodriguez F, Blazquez-Castro A, Stockert JC, Bagazgoitia L, Jaen P, Gonzalez S, Cano A, Juarranz A: Oncogenic H-Ras and PI3K signaling can inhibit E-cadherin-dependent apoptosis and promote cell survival after photodynamic therapy in mouse keratinocytes. J Cell Physi-ol 2009; 219:84-93.